Close Menu

NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Monday that its second quarter revenues rose 4 percent, driven in part by strong growth in automated sample-to-answer molecular products sales.

For the three months ended June 30, the firm reported revenues of $79.6 million, up from $76.5 million a year ago, and in line with the consensus Wall Street estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.